Furthermore, in line with previous studies that reported BTG2 as a tumor suppressor involved in multiple biological processes of cancer (Mao et al., 2015), our study identified BTG2 as a prognostic protection gene in PDAC. The gene discussed is BTG2; the disease is neoplasm.